Gilead Sciences Inc., GILD is in the exchange NASDAQ and its industry is Biotechnology in the sector of Healthcare. Based in USA, Gilead Sciences Inc., GILD has a market cap of 105932.99. Since its IPO date on the 1/22/1992, Gilead Sciences Inc., GILD performance year to date is -20.37%. Today Gilead Sciences Inc., GILD has gained -0.68%, with a current price of 79.19.
Ownership of the company is 0.50% for insider ownership while institutional ownership is 81.70%. The management of the company have seen the company have a payout ratio of 15.20%. Return of assets are at 32.70%, with return on investment at 45.90%.
In terms of debt levels and profit levels, Gilead Sciences Inc., GILD is seeing a long-term debt/equity of 0. While Total debt/equity is 0. With a profit margin of 50.50%, this is combined with a gross margin of 87.10%, and operating margin of 63.00%. Gilead Sciences Inc. ability to meet debt levels, with a current ratio of 3.1, while the quick ratio is 2.9.
For the last year Gilead Sciences Inc., GILD has seen a EPS growth of 62.00%. A performance for the year of -29.01%. The 52-week high is -31.45%, and the 52-week low is 1.64%. The average volume for Gilead Sciences Inc., GILD is 5972745.
With a target price of 106.35, can Gilead Sciences Inc., GILD reach this target? Looking at the value indicators of Gilead Sciences Inc., GILD. Gilead Sciences Inc. has a P/E of 7.02 and a forward P/E of 6.8. Perhaps the more useful indicator than P/E, is PEG which has a value of 87.8. Gilead Sciences Inc. also has a P/S and a P/B of 3.27 and 6.61 respectively. For P/cash, Gilead Sciences Inc. has a value of *TBA, while it is *TBA for P/free cash flow.
At the current price of 79.19, Gilead Sciences Inc. has a dividend yield of 2.36%. We see a return on equity of 99.90%.
Looking more long-term Gilead Sciences Inc., is projected to get an EPS growth for the next five years of 0.08%. In the short-term an EPS growth of -0.35% in the next year is forecasted. This is after a EPS growth of 62.00% for this year and for the last five years a 48.30% growth has been seen.